1. Identifying somatic mutations in cell‐free DNA of aggressive lymphoma patients: First cell‐free DNA results from the molecular profiling for lymphoma (MaPLe) study. (June 2017) Authors: Lopez Pascua, L.D.; Ahmed, S.M.; Barrans, S.; Burton, C.; Clipson, A.J.; Cucco, F.; Cutts, A.; Dreau, H.; Du, M.; Joke, D.; Mizani, R.T.; Salminen, O.; Van Hoppe, M.; Vaughan‐Spickers, N.; Schuh, A.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1460: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA. (23rd June 2022) Authors: Roddie, C.; Dias, J.; O'Reilly, M.; Green, L.; Vaughan, M.; Agliardi, G.; Garcia, J.; Lewin, E.; Lowdell, M.; Mitsikakou, M.; Charalambous, E.; Hotblack, A.; Dreau, H.; Marzolini, M.; Wood, L.; Every-Clayton, C.; Lal, A.; Ngai, Y.; Popova, B.; Malhi, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗